Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
220.00    -8.00 (-3.60%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Acquisition

5 Dec 2016 07:00

RNS Number : 8831Q
Helios Underwriting Plc
05 December 2016
 

5 December 2016

 

Helios Underwriting plc

("Helios" or the "Company")

 

Acquisition of Salviscount LLP

 

 

Acquisition of Salviscount LLP

 

Helios is pleased to announce that, in line with its strategy of increasing underwriting capacity through acquisition, on 2 December 2016 it acquired Salviscoint Limited Liability Partnership (Salviscount), a limited liability member of Lloyd's ("LLV"), for a consideration of £0.8 million in cash. The 2016 underwriting capacity of Salviscount is £1.0 million (this compares with Helios's 2016 capacity of £32.7 million prior to this acquisition). Salviscount participates in a spread of Lloyd's syndicates broadly similar to Helios's own participation. The capacity acquired, which Helios expects to retain, is as follows:

 

 Salviscount LLP

 

Year of Account

 

 

2014

2015

2016

 

£m

£m

£m

Retained

1.08

0.9

1.0

Reinsured

-

-

-

Total Capacity

1.08

0.9

1.0

 

 

Commenting upon the acquisition, Nigel Hanbury, the Company's Chief Executive Officer, said:

"We are delighted to have made a further acquisition which further increases our underwriting capacity. This is in line with our stated strategy of acquiring corporate members as suitable opportunities arise. We continue to believe that there remain significant opportunities for further growth available to the Company."

 

Additional information

Salviscount LLP (Salviscount) is a limited liability member of Lloyd's. In the year ended 31 December 2015, Salviscount made a profit before tax of £0.118m on gross premiums written of £0.881m and its net asset value at completion is expected to be approximately £0.8m, including underwriting capacity with an estimated market value of £0.4m.

 

 

Set out below are Salviscount's 2014 and 2015 open years of account forecasts:

 

YOA

Salviscount

syndicate capacity

(£'000)

Forecast of syndicate profit

(30 September 2016)

Mid point

(£'000)

Mid point

(%)

Range

(%)

2014

1,084

123

11.37

14.77% - 7.97%

2015

936

67

7.2%

11.19% - 3.20%

 

Source: Syndicate data and Helios analysis (before early release)

 

 

 

For further information please contact:

 

Helios

Nigel Hanbury - Chief Executive

Arthur Manners

 

020 7863 6655 / nigel.hanbury@huwplc.com

07754 965 917

 

 

Stockdale

Robert Finlay

 

 

020 7601 6100

 

 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £32 million of capacity for the 2016 account. The portfolio provides a good spread of classes of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQTTBRTMBJMBIF
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards
2nd Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
29th May 20257:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.